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Abstract: Angiotensin (Ang) II triggers vulnerable atherosclerotic plaque development. Bone marrow
(BM)-derived cells are key players in atherogenesis but whether Ang II induces plaque vulnerability
directly through Ang II type 1 receptor (AT1R) activation on these cells remains to be clarified.
In the present study, we investigated whether a lack of AT1R on BM-derived cells might affect Ang
II-mediated vulnerable plaque development. The 2-kidney, 1-clip (2K1C) model (Ang II-dependent
mouse model of advanced atherosclerosis and vulnerable plaques) was generated in ApoE−/−
mice transplanted with AT1aR−/− or AT1aR+/+ BM. Plasma cholesterol as well as hepatic mRNA
expression levels of genes involved in cholesterol metabolism were significantly lower in 2K1C
mice transplanted with AT1aR−/− BM than in controls. Atherosclerotic lesions were significantly
smaller in AT1aR−/− BM 2K1C mice (−79% in the aortic sinus and −71% in whole aorta compared
to controls). Plaques from AT1aR−/− BM 2K1C mice exhibited reduced lipid core/fibrous cap
and macrophage/smooth muscle cells ratios (−82% and −88%, respectively), and increased
collagen content (+70%), indicating a more stable phenotype. Moreover, aortic mRNA levels of
pro-inflammatory cytokines IL-12p35, IL-1β, and TNF-α were significantly reduced in AT1aR−/−
BM 2K1C mice. No significant differences in either the number of circulating Ly6Chigh inflammatory
monocytes and Ly6Clow resident anti-inflammatory monocyte subsets, or in mRNA levels of aortic
M1 or M2 macrophage markers were observed between the two groups. No significant differences
were observed in splenic mRNA levels of T cell subsets (Th1, Th2, Th17 and Treg) markers between
the two groups. In conclusion, direct AT1R activation by Ang II on BM-derived cells promotes
hepatic mRNA expression of cholesterol-metabolism-related genes and vascular mRNA expression
of pro-inflammatory cytokines that may lead to plaque instability.
Keywords: atherosclerosis; vulnerable plaque; Angiotensin II; inflammation; 2-kidney,
1-clip ApoE−/− mice; bone marrow transplantation
1. Introduction
Rupture of vulnerable atherosclerotic plaques is a primary underlying cause of arterial thrombosis
responsible for provoking major adverse cardiovascular events such as myocardial infarction, stroke,
and peripheral artery disease. Vulnerable plaque pathogenesis is complex but there is now clear
evidence from both observational and experimental animal studies that the renin-angiotensin system
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and its final product Angiotensin II (Ang II) have significant roles in this process. Indeed, atherosclerotic
renal artery stenosis resulting in stimulation of the renin-angiotensin system has been identified as a
predictor of cardiovascular events in high-risk patients [1]. Moreover, we provided first experimental
evidence that Ang II directly induces plaques with a vulnerable phenotype in the apolipoprotein
E-deficient (ApoE−/−) mouse [2]. Despite the above evidence, the precise cellular and molecular
mechanisms through which Ang II contributes to plaque vulnerability remain incompletely defined [3].
Most of the proatherosclerotic actions of Ang II are primarily mediated by the Ang II type 1
receptor (AT1R). Accordingly, clinical studies have demonstrated that the pharmacological blockade of
AT1R reduces cardiovascular morbidity and mortality in high risk patients [4]. Both genetic disruption
and pharmacological blockade of AT1R also reduce atherosclerosis severity in ApoE−/− mice [5–9].
Similarly, we showed that AT1R blockers prevent Ang II-induced vulnerable plaque development
in the 2-kidney, 1-clip (2K1C) apoE−/− mouse model [10,11]. AT1R are expressed in immune cells
derived from haematopoietic cells in the bone marrow (BM), including macrophages and CD4+ T cells
which are the surrogate cells of innate and adaptive immunity, respectively, playing central roles in
atherogenesis [12]. A crucial role for AT1R on BM-derived cells in mediating the pro-atherosclerotic
effects of Ang II has, therefore, been suggested; however, the few existing studies using ApoE−/− or
low density lipoprotein receptor-deficient (LDLr−/−) mice infused with exogenous Ang II have yielded
inconsistent results [13–15]. Hence, it remains unclear whether Ang II induces plaque vulnerability
through direct AT1R activation on BM. Moreover, mechanisms downstream of Ang II-mediated AT1R
activation promoting plaque vulnerability remain largely unknown.
The aim of the present work was to examine the effects of AT1R deficiency within BM-derived
cells on Ang II-induced advanced atherosclerosis and plaque vulnerability using the 2K1C apoE−/−
mouse model.
2. Results
Irradiated ApoE−/− mice were transplanted with either AT1aR−/− or AT1aR+/+ (Wild-type) BM,
and were subjected to left renal artery clipping for 4 weeks to allow development of Ang II-dependent
advanced and vulnerable plaques (2K1C model). A total of n = 29 AT1aR−/− → ApoE−/− 2K1C mice
and n = 22 AT1aR+/+ → ApoE−/− 2K1C control mice were analyzed.
2.1. Physiological Parameters of Transplanted 2K1C ApoE−/− Mice
As shown in Table 1, there was no significant difference in body weight (BW) gain, mean blood
pressure (MBP), heart rate (HR), plasma renin activity (PRA), and plasma renin concentration (PRC)
between the two groups of mice at the end of the study. Plasma total cholesterol (PTC) significantly
decreased in 2K1C AT1aR−/− → ApoE−/− (p < 0.0001 versus control mice).
Table 1. Physiological parameters in 2K1C ApoE−/− mice transplanted with AT1aR+/+ or AT1aR−/−




BW gain (g) 2.26 ± 0.32 1.76 ± 0.28 0.255
MBP (mmHg) 133 ± 3 132 ± 3 0.755
HR (bpm) 602 ± 15 626 ± 15 0.269
PRA (ng/mL per h) 13.1 ± 1.4 15.1 ± 1.2 0.289
PRC (ng/mL per h) 1307 ± 169 1282 ± 155 0.913
PTC (g/L) 6.5 ± 0.15 3.5 ± 0.10 p < 0.0001
2.2. AT1aR Deficiency in BM-Derived Cells Modulates Cholesterol Metabolism
Figure 1 shows that the hepatic mRNA expression of HMG-CoA reductase (Hmgcr), LDL receptor
(Ldlr), sterol regulatory element binding transcription factor 2 (Srebf2), and apolipoprotein B (ApoB)
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were significantly decreased in 2K1C ApoE−/− transplanted with AT1aR−/− BM compared to control
mice. Acat2 hepatic mRNA expression was similar between the two groups (Figure 1).
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Figure 1. Effect of AT1aR deficiency in BM-derived cells on genes involved in cholesterol metabolism.
mRNA levels of Hmgcr, Ldlr, Srebf2, ApoB, and Acat2 were determined in liver tissue by real-time
RT-PCR analysis. Data were normalized to 36B4 and expressed as fold change over controls which
were set at 1. n = 9 animals per group.
2.3. AT1aR Deficiency in BM-Derived Cells Prevents Ang II-Induced ATS
Quantification of atherosclerosis in aortic preparations stained with Oil red O revealed a significant
71% decrease in atherosclerotic plaque surface in 2K1C AT1aR−/− → ApoE−/− mice compared to
control ones (0.29 ± 0.04% versus 1.01 ± 0.21%; Figure 2A,B). Similarly, a significant 79% decrease in
aortic sinus plaque surface was observed in 2K1C AT1aR−/− → ApoE−/− mice (58,519 ± 8664 µm2
versus 274,667 ± 24,859 in controls; Figure 2C,D).
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Figure 2. Effect of AT1aR deficiency in BM-derived cells on Ang II-mediated atherosclerosis.
(A) Representative photographs of pinned-out aortas en face stained with Oil red O (lipid staining)
from 2K1C ApoE−/− mice transplanted with either AT1aR+/+ or AT1aR−/− BM; (B) quantitative
morphometric analysis of aortic plaque surface expressed as % of lipid deposition of the total aortic area
analyzed (n = 7 to 11 animals per group); (C) representative photographs of aortic sinus cross-sections
stained with Movats pentachrome (scale bar = 200 µm); (D) quantitative morphometric analysis of
aortic sinus plaque area expressed in µm2 (n = 13 to 16 animals per group). Circles represent individual
mice, horizontal lines indicate the mean, and error bars represent SEM.
2.4. AT1aR Deficiency in BM-Derived Cells Prevents Ang II-Mediated Plaque Vulnerability
Plaque staging significantly differed among the two groups of mice. All control mice developed
advanced lesions whereas these were present in 63% of 2K1C AT1aR−/− → ApoE−/− mice animals
(p < 0.05; Figure 3A–C). Compared to plaques from control mice, those from 2K1C AT1aR−/−
→ ApoE−/− exhibited no buried cap, and showed reduced frequency of adventitia inflammation
(p < 0.001, Figure 3A–C). Moreover, the lipid core area was significantly decreased by 68%, while fibrous
cap area tended to increase in 2K1C AT1aR−/− → ApoE−/− BM mice compared to controls (lipid
core area: 9.0 ± 2.0% versus 27.9 ± 2.6%, p < 0.0001; fibrous cap area: 5.9 ± 1.6% versus 2.2 ± 0.8%,
p = 0.06) (Figure 3A,B,D). Overall, a significant 82% reduction in lipid core size to fibrous cap ratio was
observed in 2K1C AT1aR−/− → ApoE−/− BM (p < 0.01 versus control, Figure 3E).
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Further analysis of plaque composition in 2K1C AT1aR−/−→ApoE−/− BM revealed a significant
74% reduction in macrophage content (7.7 ± 1.9% versus 29.9 ± 3.1%, p < 0.0001) and a significant 83%
increase in smooth muscle (SM) cell number of (31.7 ± 4.9% versus 17.3 ± 2.6%, p < 0.05) accompanied
by a 70% increase number of collagen fibers (35.8 ± 4.2% versus 21.1 ± 3.4%, p < 0.05) (Figure 4A,B).
Mac-2 to α-SM actin ratio was significantly lower in 2K1C AT1aR−/− → ApoE−/− BM group (−88%,
p < 0.0001; Figure 4C).
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Figure 4. AT1aR deficiency in BM-derived cells prevents Ang II-mediated vulnerable plaques
containing a high number of macrophages, and low content of SM cells and collagen. (A) Representative
photographs of aortic sinus cross-sections immunostained for Mac-2 (top panel) and α-SM actin (middle
panel) for macrophage and SM cells determination, respectively, or stained with Sirius Red (bottom
panel) for collagen determination in 2K1C ApoE−/− mice transplanted with either AT1aR+/+ or
AT1aR−/− BM (scale bar = 100 µm). (B) Quantification of Mac-2, α-SM actin, and Sirius Red positive
staining over the total area of plaque. (C) Quantification of Mac-2 to α-SM actin ratio. Data are
mean ± SEM. n = 12 to 16 animals per group.
2.5. AT1aR Deficiency in BM-Derived Cells Does Not Modulate Monocyte Recruitment
Aortic expression of intercellular adhesion molecule-1 (ICAM-1) and macrophage migration
inhibitory factor (MIF) was similar between 2K1C AT1aR−/− → ApoE−/− BM and control mice
(Figure 5). Vascular cell adhesion molecule-1 (VCAM-1) expression was not detected in any of
the groups.
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2.6. AT1aR Deficiency in BM-Derived Cells Leads to Decreased Vascular Inflammatory State
Figure 6A shows that aortic expression of pro-inflammatory cytokines interleukin (IL)-1β,
IL12p35, and tumor necrosis factor (TNF)-α significantly decreased 5-fold (p < 0.01), 5.6-fold
(p < 0.05), and 12.5-fold (p < 0.05), respectively, in 2K1C AT1aR−/− → ApoE−/− BM compared to
controls. No significant differences in expression of pro-inflammatory interferon (IFN)-γ, and IL-6,
or anti-inflammatory IL-10 cytokines were observed between the two groups. Neither CD11c M1
macrophage marker, nor CD206 M2 macrophage marker expression, nor CD11c to CD206 ratio
significantly differed among the two groups (Figure 6B).
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Figure 6. Effect of AT1aR deficiency in BM-derived cells on vascular expression of cytokines and
macrophage phenotype markers. (A) mRNA levels of pro-inflammatory cytokines IL-1β, IL12p35,
TNF-α, IL-6 and IFN-γ as well as anti-inflammatory cytokine IL-10; (B) mRNA levels of M1-associated
marker CD11c as well as M2-associated marker CD206. mRNA levels were determined in aortic tissue
by real-time RT-PCR analysis. Data were normalized to 36B4 and expressed as fold change over controls
which were set at 1. Error bars are the SEM of the ∆CT values; (C) Quantification of CD11c to CD206
ratio (M1/M2 balance marker). n = 3 to 10 animals per group.
2.7. AT1aR Deficiency in BM-Derived Cells Does Not Affect Systemic T Helper Cells Subtypes
No statistical differences between 2K1C AT1aR−/− → ApoE−/− BM and control mice were
observed in splenic expression of T helper type 1 (Th1) markers T-bet and IL-2 (Figure 7A); T helper
type 2 (Th2) markers GATA3 and IL-13 (Figure 7B); regulatory T cells (Treg) markers IL-10 and
transforming growth factor (TGF)-β (Figure 7C); and T helper type 17 (Th17) marker IL-17 (Figure 5D).
Consequently, neither T-bet to GATA3 and IL-2 to IL-13 calculated ratios (Th1/Th2 balance markers)
(Figure 7E), nor IL-10 to IL-17 and TGF-β to IL-17 ones (Treg/Th17 balance markers) (Figure 7F) were
significantly different between groups.
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Figure 7. Effect of AT1aR deficiency in BM-derived cells on systemic expression of CD4+ T
cells phenotype markers. mRNA levels of pro-inflammatory Th1 markers T-bet and IL-2 (A),
anti-inflammatory Th2 markers GATA3 and IL-13 (B), Treg markers IL-10 and TGF-β (C), and Th17
marker IL-17 (D). mRNA levels were determined in splenic tissue by real-time RT-PCR analysis.
Data were normalized to 36B4 and expressed as fold change over controls which were set at 1. Error bars
are the SEM of the ∆CT values. Quantification of T-bet to GATA3 and IL-2 to IL-13 ratios (Th1/Th2
balance markers) (E), and of IL-10 to IL-17 and TGF-β to IL-17 ratios (Treg/Th17 balance markers) (F).
n = 10–12 animals per group.
2.8. AT1aR Deficiency in BM-Derived Cells Does Not Modulate Systemic Macrophages Phenotype
As shown in Figure 8A, CD11c (p < 0.0001), and CD206 (p < 0.01) mRNA expression
significantly similarly decreased in 2K1C AT1aR−/− → ApoE−/− BM (6.7-fold and 5.6-fold,
respectively, versus controls), resulting in a non-significant CD11c to CD206 ratio compared to control
mice (Figure 8B).
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Figure 8. Effect of AT1aR deficiency in BM-derived cells on the systemic expression of macrophage
phenotype markers. (A) mRNA levels of pro-inflammatory M1 macrophage marker CD11c,
and anti-inflammatory M2 macrophage marker CD206. (B) Quantification of CD11c to CD206 ratio.
(C) mRNA levels of M1-related pro-inflammatory cytokines IL-1β, TNF-α, IL-18 and of M2-related
anti-inflammatory cytokine IL-1ra. mRNA levels were determined in splenic tissue by real-time RT-PCR
analysis. Data were normalized to 36B4 and expressed as fold change over controls which were set
at 1. (D) Plasma levels of IL-1β and TNF-α as determined by ELISA. n = 10–12 animals per group for
real-time RT-PCR analysis. n = 4–8 animals per group for ELISAs; ND = Non detected.
Neither M1-related cytokines IL-1β, TNF-α and IL-18, neither M2-related cytokine IL-1ra differed
significantly between the two groups (Figure 8C). In accordance, ELISAs showed similar TNF-α protein
concentration in plasma between the two groups while IL-1β could not be detected (Figure 8D).
2.9. AT1aR Deficiency in BM-Derived Cells Do Not Impact Circulati g Leukocyte Profile
Percentage of circulating CD3+ B220− T cells, CD4+ CD8− T-helper cells, CD4− CD8+ cytotoxic T
cells, CD3− B220+ B cells, CD11b+ Ly6G+ neutrophils, and CD11b+ Ly6G monocytes, subdivided into
Ly6Chigh inflammatory classical, Ly6Cmed resident, and Ly6Clow non classical monocytes subsets are
shown in Table 2.
Compared to controls, T cell percentage was significantly lower in 2K1C AT1aR−/− → ApoE−/−
BM (−26%, p < 0.05), although no significant difference was observed in T-helper cell and cytotoxic T
cell subsets. Percentage of B cells, neutrophils, and monocytes were not significantly different between
the two groups. Further analysis of monocyte subsets revealed no significant difference for any of
them among the two groups. Classical to nonclassical monocytes ratio was similar between the two
groups (Table 2).
Int. J. Mol. Sci. 2018, 19, 2621 10 of 16
Table 2. Flow cytometry analysis of blood leukocytes in 2K1C ApoE−/− mice transplanted with
AT1aR+/+ or AT1aR−/− BM mice.
Parameter Markers 2K1CAT1aR+/+→ ApoE−/−
2K1C
AT1aR−/−→ ApoE−/− p-Value
T cells (% of viable cells) CD3+ B220− 21.8 ± 1.3 16.2 ± 1.5 0.011
T-helper cells (% of T cells) CD4+ CD8− 26.9 ± 1.0 26.6 ± 0.7 0.804
Cytotoxic T cells (% of T cells) CD4− CD8+ 67.3 ± 1.9 70.6 ± 0.7 0.131
B cells (% of viable cells) CD3− B220+ 15.3 ± 3.8 7.8 ± 1.1 0.082
Granulocytes (% of viable cells) CD11b+ Ly6G+ 29.3 ± 5.0 35.4 ± 3.0 0.314
Monocytes (% of viable cells) CD11b+ Ly6G− 12.3 ± 1.9 11.0 ± 1.8 0.536
Classical monocytes (% of monocytes) Ly6Chigh 20.7 ± 3.2 22.0 ± 2.4 0.745
Intermediate monocytes (% of monocytes) Ly6Cmedium 21.0 ± 1.1 19.7 ± 0.5 0.322
Nonclassical monocytes (% of monocytes) Ly6Clow 58.3 ± 3.4 58.3 ± 2.5 0.987
Classical/nonclassical monocytes Ly6Chigh/Ly6Clow 0.383 ± 0.076 0.393 ± 0.054 0.917
3. Discussion
Major findings presented herein are (a) Ang II drives atherosclerosis and plaque vulnerability
through direct BM-derived cells activation of AT1R; (b) AT1R BM-derived cells activation leads to
a reduced plasma cholesterol level that is associated with a decreased expression of genes involved
in cholesterol metabolism, and to decreased aortic pro-inflammatory cytokines expression; (c) AT1R
BM-derived cells activation does not modulate aortic and splenic M1 and M2 macrophage polarization,
does not modulate the splenic expression pattern of Th1, Th2, Th17, and Treg markers, and finally
does not impact circulating monocytes subtypes.
Macrophages and CD4+ T cells have been shown to play a key role in atherogenesis via several
mechanisms implicating inflammation and cholesterol homeostasis among others [16]. Hence, it has
been hypothesized that Ang II may induce its pro-atherosclerotic effects through direct stimulation of
these immune cells AT1R. However, existing experimental studies testing this hypothesis in a mouse
model of infused Ang II-induced atherosclerosis showed controversial results [13–15]. Two studies
demonstrated that AT1R in BM-derived cells is involved in Ang II-induced atherosclerotic plaque
development and destabilization [13,14] whereas the study of Koga et al. failed to observe any
pro-atherosclerotic effect [15]. Conflicting reports have also been reported in hypercholesterolemic
mice without Ang II stimulation [17–19]. To clarify the role of AT1R in Ang II-dependent atherosclerosis,
we used the 2K1C ApoE−/− mouse model generated in our laboratory [2]. Contrary to previous reports
where the model of Ang II-dependent atherosclerosis was induced using exogenous administration of
high doses of Ang II via minipumps [13–15], the 2K1C model is characterized by increased endogenous
Ang II production in response to renal renin secretion stimulation. In the 2K1C model, all the
physiological mechanisms of the renin-angiotensin-system are taken into account, as it occurs in
humans. Using this model, our data showed that the absence of BM-derived cells AT1R strongly
attenuates not only Ang II-induced plaque development acceleration, but also vulnerable plaque
development (i.e., decreased macrophages and lipid core area, and increased SM cells, collagen,
and fibrous cap area).
Several mechanisms of action may underline reduced atherosclerosis severity in 2K1C ApoE−/−
mice lacking AT1R in BM-derived cells. Cytokines regulate immune and non-immune cells in the
vasculature thus influencing either anti- or pro-atherogenic processes [20]. We therefore tested whether
the lack of AT1R on BM-derived cells affects the inflammatory state in the vascular wall of 2K1C
ApoE−/− mice. The present study shows significant aortic reduction in pro-inflammatory cytokines
IL-1β, IL-12p35 and TNF-α in the 2K1C ApoE−/− mice lacking the AT1R. Because of the increased
inflammatory cells in atherosclerosis, this inevitably leads to enhanced pro-inflammatory cytokines
and inversely, the decreased vascular inflammation in 2K1C mice lacking BM-derived cells AT1R could
be directly related to the reduced plaque macrophage accumulation in those mice.
Adhesion molecules such as ICAM-1 and VCAM-1 as well as the cytokine MIF regulate
monocyte/macrophage recruitment to the plaques [21,22]. In the present study, no significant
difference in ICAM-1 and MIF vascular expression was observed in our mice (the expression
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of VCAM-1 was undetectable), suggesting that other mechanisms than a modulation of
monocyte/macrophage recruitment may account for Ang II-AT1aR on BM-derived cells
signaling-induced plaque macrophage accumulation.
Numerous studies in patients and mice have shown that a sustained cholesterol reduction is
beneficial for preventing the progression of atherosclerosis [23,24]. Here, we showed that BM AT1R
deficiency in 2K1C ApoE−/− mice leads to a reduced plasma total cholesterol level, which may
directly account for the reduced lesion formation in these mice. To explore the underlying molecular
mechanisms, we examined the hepatic expression of several genes involved in cholesterol metabolism,
including the rate-limiting enzyme of cholesterol synthesis (Hmgcr); Ldlr; srebf2 (the transcription
factor regulating both Hmgcr and Ldlr); apoB; and Acat2, the hepatic cholesterol esterifying
enzyme [25]. In agreement with our finding, expression of Hmgcr, Ldlr, Srebf2, and ApoB is lower in
2K1C mice lacking BM-derived cells AT1R. Taken together, our results strongly suggest that Ang II
signaling in BM-derived cells affects cholesterol metabolism in vivo.
In order to obtain further mechanistic insights, we explored the phenotype of vascular
macrophages and circulating monocytes. To our knowledge, the present study is the first to investigate
whether Ang II-activated BM-derived cells AT1R affect both lesional macrophages, and circulating
monocytes activation in the setting of atherosclerosis. AT1R may directly modulate macrophage
phenotype. Indeed, following pharmacological blockage of AT1R, a change in macrophage phenotype
has been shown in kidney and adipose tissue in an obesity-related kidney injury model and high-fat-fed
mice [26,27]. Interestingly, Yamamoto et al. recently reported decreased M1 macrophages in
atherosclerotic lesions of ApoE−/− mice transplanted with AT1R−/− BM but with normal Ang II
circulating levels [19]. Our results, showing decreased expression of pro-inflammatory cytokines in
mice lacking BM-derived cells AT1R further sustain a potential polarization of vascular macrophages
toward a less pro-inflammatory state. In the present study, however, we did not observe any significant
differences in M1 and M2 markers expression and M1/M2 expression ratio in the aorta, despite a
decrease in total macrophages plaque content in 2K1C mice lacking BM-derived cells AT1R. Differences
between our study and that of Yamamoto et al. could be explained by different mouse models used.
In our 2K1C mouse model, Ang II induces the development of severe and vulnerable plaques whereas
Yamato et al. used ApoE−/− mice with a non-stimulating renin-angiotensin system resulting in less
atherosclerosis severity. In support of our findings, attenuation of murine atherosclerosis by reducing
macrophages infiltration but not polarization has been shown by others [28].
Monocytes are key mediators in atherogenesis since they are converted in macrophages after their
migration from the circulation into the intima of the arterial wall. Monocytes can also be differentiated
into two distinct populations, which can be distinguished by well-characterized surface protein
expression profiles. In mouse blood, classical inflammatory monocytes are identified by Ly6Chigh
expression, whereas non-classical alternative monocytes are Ly6Clow. The literature shows that classical
monocytes are precursors of M1 macrophage. In addition, studies suggest that non-classical monocytes
differentiate into resident or M2 macrophages although the exact origin of M1 and M2 macrophages
in atherosclerotic lesions remain to be confirmed [29]. Flow cytometry analysis showed that AT1R
deficiency in 2K1C ApoE−/− mice does not impact percentages of total monocytes, Ly6Chigh monocyte
subset, and Ly6Chigh monocyte subset in the circulation. This result is in line with the results above
(i.e., no change in vascular macrophage phenotype among the two groups).
Taken together, data presented herein indicate for the first time that polarization of vascular
macrophages and circulating monocytes is not a primary mechanism underlying Ang II-induced
plaques destabilization though AT1R on BM-derived cells.
Th1 cells have been shown to be pro-atherogenic, while Treg have anti-inflammatory and
anti-atherogenic properties. The role of Th2 and Th17 remains controversial [12]. A recent study
demonstrated that valsartan attenuates atherosclerosis via an increase in Th1 and Th17 and a decrease
in Th2 and Treg cells in prolonged Ang II-treated ApoE−/− mice [30]. One could therefore hypothesize
that AT1R deficiency in BM-derived cells may shift CD4+ T cells polarization toward Th2- and/or
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Treg-oriented phenotype in our 2K1C mouse model. Gene expression analysis of Th1/Th2/Th17
and Treg signature transcription factors and/or cytokines in splenic tissue revealed no difference.
The present findings are not surprising; given that Th1 and Th2 elicit M1 and M2 macrophage
phenotypic polarization as explained before, and that we observed no change in macrophage
polarization between our groups.
Systemic inflammation responses are considered to play a major role in the destabilization of
atherosclerotic plaques [31]. Our study did not reveal significant differences in splenic expression of
pro- and anti-inflammatory cytokines as well as in the plasma level of TNF-α between the two groups.
Thus, we speculate that systemic inflammation does not account for the pro-atherosclerotic effect of
BM-derived cells ATR1 activation by Ang II.
4. Materials and Methods
4.1. Animals and Bone Marrow Transplantation
C57BL/6 ApoE−/− mice originally obtained from Charles River Laboratory (L’Arbresle, France)
were used as recipients. C57BL/6 AT1aR+/+ (WT) and C57BL/6 AT1aR−/− mice originally purchased,
respectively, from The Jackson Laboratory (Bar Harbor, ME, USA) and Charles River Laboratory were
used as donors. All the mice were bred and maintained in our local animal facility in individually
ventilated cages with standard rodent chow and water available ad libitum. BM transplantation
study was performed according to previously published protocols [13,32]. Briefly, 12–14 week-old
female ApoE−/− mice were lethally irradiated with a total of 900 rads using a 137Cs source that
was delivered in two doses (4 h apart) to induce BM aplasia. On the day following irradiation,
recipient mice were transplanted with BM cells freshly isolated from either AT1aR−/− or AT1aR+/+
male mice (16–20 week-old) by injection of 1 × 107 BM cells (in 200 µL of sterile PBS) per mouse into
the tail vein. In brief, BM cells were isolated from pooled donor mice by flushing femur and tibia
bones with ice-cold PBS-BSA 1%. Mice were maintained on antibiotic water for 1 week before BM
transplantation until 2 weeks after. Successful BM transplantation was confirmed by PCR analysis of
blood Sry (Y chromosome marker) DNA (Figure S1).
Four weeks after BM constitution, mouse model of Ang II-mediated vulnerable plaque was
generated in transplanted mice as described below.
All experiments were approved by the local institutional animal committee (Service de la
consommation et des affaires vétérinaires, approval number: VD2793, 16 January 2014).
4.2. Mouse Model of Ang II-Mediated Vulnerable Atherosclerotic Plaques
The renin-dependent Ang II-mediated 2K1C model was generated as originally described by
our laboratory [2]. Briefly, a U-shaped stainless steel clip (0.12 mm internal diameter) was placed
around the left renal artery in isoflurane-anesthetized mice, reducing renal blood flow and renal
perfusion pressure.
Four weeks after renal artery clipping (i.e., 8 weeks after BM transplantation), MBP and HR were
measured from a carotid catheter as previously described [2]. Blood samples were collected from the
catheter for PRA and PRC measurements as described in detail earlier [10].
4.3. Determination of Atherosclerotic Plaque Size by Histology
To evaluate the extent of atherosclerosis, two alternative methods were used: Analysis of
atherosclerotic plaque surface en face in whole aortas and in cross-sections of the aortic sinus,
as described previously [2,33]. In brief, after perfusion of the left ventricle with cold PBS, the heart and
the thoracoabdominal aorta were dissected and fixed in 3.7% formalin. The aorta was then opened
longitudinally, pinned on a black silicone-covered dish, and stained with Oil red O. Pictures of stained
aortas were taken with a digital camera (Coolpix, Nikon, Tokyo, Japan), and the surface areas of total
pinned aorta and Oil red O-stained areas were measured using computer-assisted image analysis
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Qwin software (Leica systems, Wetzler, Germany). Aortic plaque area was expressed as the percentage
of positive Oil red O area over the total area of the aorta.
The heart was embedded in paraffin and cross-sectioned (3 µm-thick) until reaching the aortic
sinus. Sections were then stained with Movats pentachrome and photographed using a digital camera
(Leica DC300F Camera, Wetzler). Pictures were then analyzed by using the Qwin software and aortic
sinus plaque was expressed in µm2.
4.4. Evaluation of Atherosclerotic Plaque Staging and Phenotype by Histology and Immunohistochemical Analyses
Atherosclerotic plaque analysis was performed as previously described [2,34]. Briefly,
Movats pentachrome cross-sections of the aortic sinus were used for plaque classification. Plaques were
classified as intermediate (essentially composed of foam cells or with a small lipid core) or advanced
(large necrotic/lipid core with multiple layers). In addition, characteristic features of plaque
vulnerability were evaluated: (1) fibrous cap surface area (% of plaque surface), (2) lipid core surface
area (% of plaque surface), (3) presence of media degeneration (media atrophy and/or invasion of
media by plaque components), (4) presence of buried cap (defined as fibrous cap within lesions),
(5) presence of adventitia inflammation (>20 polymorphonuclear cells), (6) macrophage plaque content
(% of plaque surface), (7) SM cell plaque content (% of plaque surface), and (8) plaque total collagen
content (% of plaque surface).
Macrophage and SM cells in plaque were identified by immunostaining with primary anti-mouse
monoclonal Mac-2 and α-SM actin antibodies, respectively, followed by the appropriate biotinylated
secondary antibodies. Plaque total collagen content was determined using Sirius red staining.
Quantitative analysis was performed under light microscopy by means of the Qwin software.
4.5. Quantification of Gene Expression by Real-Time RT-PCR
In brief, total RNA was isolated from aortas and spleens using the RNeasy Fibrous Tissue Mini
Kit or RNeasy Mini Kit (Qiagen, Hombrechtikon, Switzerland), respectively. Total RNA from liver was
extracted using Trizol, then purified using the RNeasy MinElute Cleanup Kit (Qiagen, Hombrechtikon,
Switzerland). RNA concentration and purity were measured with a spectrophotometer (Nanodrop
2000c, Thermo Scientific, Waltham, MA, USA). cDNA was then synthesized by reverse transcription
using the iScriptT™ cDNA Synthesis Kit from Bio-Rad (Cressier, Switzerland). Quantitative real-time
PCR was performed on a CFX96 Real-Time PCR detection system (Bio-rad, Cressier, Switzerland) in
96-well PCR plates using iQ™ SYBR® Green Supermix (Bio-Rad, Cressier, Switzerland) according to
the manufacturer’s protocols. The pairs of mouse primers were listed in Table S1. Data were analyzed
using the comparative threshold cycles (CT) method using the housekeeping control gene 36B4 for
normalization. All procedures were performed as described in previous reports [11,34].
4.6. Plasma Cholesterol and Cytokines Determination
PTC was determined in plasma obtained by a carotid catheter at sacrifice using a commercial kit
(Cholesterol FS, Diasys France). Plasma cytokines IL-1β and TNF-α were determined using mouse
IL-1β/IL-1F2 and TNF-α Quantikine® ELISA kits (R&D Systems Europe, Ltd., Minneapolis, MN,
USA), respectively, according to the manufacturer’s instructions.
4.7. Analysis of Blood Leukocytes by Flow Cytometry
Blood samples obtained from the carotid catheter were processed for flow cytometry analysis
according to a previously published protocol [35], with slight modifications. Briefly, after lysis of
erythrocytes with a commercial lysis buffer (eBioscience, Waltham, MA, USA), cells were stained
with anti-mouse CD16/CD32 antibody at 4 ◦C for 5 min in the dark. Then, cells were labelled with
fluorochrome-conjugated antibodies at 4 ◦C for 10 min in the dark in two separate mixtures. Mixture 1
was used to stain T cell subsets and B cells and included the following antibodies: PE-Cy7 anti-CD3,
PE anti-CD4, FITC anti-CD8, and PE-Cy5 anti-CD45R/B220. Mixture 2 was used to stain granulocytes,
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monocytes, and monocyte subsets (classical versus resident versus intermediate versus nonclassical),
and included the following antibodies: PE anti-Ly-6G, FITC anti-Ly-6C, and PE-Cy7 anti-CD11b.
Isotype-matched controls antibodies were used as negative controls. The cells were subsequently
washed with 2 mL of Flow Cytometry Staining Buffer (eBiosciences) by centrifugation (5 min at
2000 rpm), and resuspended in 500 µL Flow Cytometry Staining Buffer. Samples were run on a
Beckman Coulter Cytomics FC500 flow cytometer and data were analyzed with the Kaluza software
(version 1.3, Beckman Coulter Indianapolis, IN, USA). A total of 50,000 events were acquired per
sample. Antibodies were purchased from BD Pharmingen and Biolegend. Immune cell populations in
whole blood were gated as illustrated in Figure S2.
4.8. Statistical Analysis
Data are expressed as mean ± SEM unless otherwise indicated. The unpaired two-tailed t-test
was used for comparisons between the two groups. Statistical analysis of atherosclerotic plaque
staging was carried out using the Fisher’s exact test. All analyses were performed using GraphPad
Prism version 7.03 (GraphPad Software, La Jolla, CA, USA), and values of p < 0.05 were considered
statistically significant.
5. Conclusions
In conclusion, our results provide support of a direct role of BM-derived cells AT1R in Ang
II-induced atherosclerosis burden and plaque vulnerability. AT1R activation promotes hepatic
mRNA expression of cholesterol-metabolism-related genes and vascular mRNA expression of
pro-inflammatory cytokines. This study sheds light on mechanisms mediating the pro-atherosclerotic
effect of Ang II, and might open the door to new therapeutic approaches to prevent vulnerable
plaque development.
Supplementary Materials: The following are available online at http://www.mdpi.com/1422-0067/19/9/2621/
s1, Figure S1: Assessment of BM engraftment, Table S1: Mouse primers for quantitative real-time RT-PCR,
Figure S2: Flow cytometry gating strategy for analysis of cell populations in whole blood from 2K1C ApoE−/−
mice transplanted with AT1aR+/+ or AT1aR−/− BM.
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